Ocular involvement in Mycoplasma induced rash and mucositis: A systematic review of the literature.

Autor: Haseeb A; Department of Ophthalmology, Nazareth Hospital, Philadelphia, PA, USA; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA., Elhusseiny AM; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA; Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: abdelrhman.elhussieny@gmail.com., ElSheikh RH; Department of Ophthalmology, Kasr Al-Ainy Hospitals, Cairo University, Cairo, Egypt., Tahboub MA; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA., Kwan JT; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA., Saeed HN; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA; Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA; Department of Ophthalmology, Loyola University Medical Center, Maywood, IL, USA. Electronic address: hnsaeed@uic.edu.
Jazyk: angličtina
Zdroj: The ocular surface [Ocul Surf] 2023 Apr; Vol. 28, pp. 1-10. Date of Electronic Publication: 2022 Nov 14.
DOI: 10.1016/j.jtos.2022.11.007
Abstrakt: Mycoplasma pneumoniae induced rash and mucositis (MIRM) is a relatively newly identified clinical entity which is characterized by mucocutaneous manifestations in the setting of Mycoplasma infection. Though a clinically distinct disease, MIRM exists on a diagnostic continuum with entities including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, and the recently described reactive infectious mucocutaneous eruption (RIME). In this systematic review, we discuss published findings on the epidemiology, clinical manifestations, diagnosis, and management of MIRM, with an emphasis on ocular disease. Lastly, we discuss some of the most recent developments and challenges in characterizing MIRM with respect to the related diagnosis of RIME.
Competing Interests: Declaration of competing interest The authors have no disclosures to make regarding financial or personal relationships with other people or organizations which could bias their work. They have no conflicts of interest to disclose.
(Copyright © 2022. Published by Elsevier Inc.)
Databáze: MEDLINE